These findings highlight distinct, peptide-specific responses to HD and support a context-dependent interplay between uremic burden, peptide systems, and dialysis-induced shifts. Apelinergic and RAS peptides may represent promising biomarkers of intradialytic cardiovascular modulation. Further studies are warranted to explore their prognostic and therapeutic implications in CKD.
Serwin et al. (Thu,) studied this question.